The role of diet in diabetes gastroparesis treatment: a systematic review and meta-analysis

Dezhi Lin, Hui Wang, Yangxu Ou, Longlong Li, Qiang Zhang, Jiayin Yan, Dezhong Peng, Sihan PengFrontiers in Endocrinology 2024 · DOI

Abstract

Diabetic gastroparesis (DGP) is a debilitating complication of diabetes characterized by delayed gastric emptying in the absence of mechanical obstruction. This systematic review and meta-analysis of 15 randomized controlled trials (RCTs) evaluates the efficacy of Personalized Dietary Care (PDC) compared to Routine Dietary Care (RDC). The findings demonstrate that tailored nutritional interventions—focusing on food form, fiber content, and meal frequency—significantly improve gastric motility, clinical efficacy, and glycemic control, offering a safe and effective first-line therapy for DGP patients.

Introduction

Diabetic gastroparesis (DGP) presents a complex clinical challenge, manifesting as chronic nausea, vomiting, and bloating. These symptoms not only diminish quality of life but also create a volatile environment for blood glucose management. While pharmacological treatments like prokinetic drugs are available, they often carry risks of severe side effects, such as tardive dyskinesia. Consequently, dietary intervention has emerged as a critical "green" therapy. This study aims to quantify the impact of personalized nutrition plans on both gastric function and metabolic outcomes compared to standard medical advice.

Methodology

The researchers performed a systematic review and meta-analysis in accordance with PRISMA guidelines. A comprehensive search across eight major databases, including PubMed, EMBASE, and several Chinese-language databases (CNKI, VIP, CBM, WanFang), identified relevant RCTs published through November 2023.

PRISMA flow chart detailing the study selection process.

The search strategy utilized specific MeSH terms and keywords related to diet, diabetes, and gastroparesis to ensure a robust evidence base. The final analysis included 15 RCTs involving a total of 1,106 participants.

Search strategy and terms used for database identification.

The primary outcomes measured were Gastric Emptying Time (GET) and Clinical Efficacy (CE), while secondary outcomes included Fasting Blood Glucose (FBG), 2-hour Postprandial Blood Glucose (2hPBG), and Glycosylated Hemoglobin (HbA1c).

Key Insights and Clinical Results

The meta-analysis revealed that Personalized Dietary Care (PDC) is superior to generic advice across all measured variables.

The Importance of Personalization

PDC involves a dynamic feedback loop where nutritional status is assessed, and recipes are tailored to the patient's physical condition and glucose fluctuations. This approach proved significantly more effective than standard "Routine Dietary Care" (RDC), which typically provides generic nutritional advice.

Dietary Composition and Form

Successful interventions emphasized a shift toward semi-liquid or liquid foods and a "small and frequent" meal approach. Liquids bypass impaired gastric grinding mechanisms more efficiently than solids. Furthermore, contrary to standard diabetic advice, a low-fiber, low-fat diet was recommended for DGP patients to prevent the formation of bezoars and avoid further delays in emptying.

Quantitative Outcomes

  • Gastric Motility: PDC significantly reduced GET compared to routine care (Mean Difference = -0.51; $P < 0.00001$).
  • Clinical Success: Patients in the PDC group were over four times more likely to show significant clinical improvement (OR = 4.44).
  • Glycemic Control: Significant reductions were observed in FBG, 2hPBG, and HbA1c. Notably, the mean difference in HbA1c was -1.71% favoring the PDC group.

Conclusion and Limitations

Personalized dietary intervention represents a highly effective and safe therapeutic strategy for managing DGP, showing clear benefits for both stomach motility and blood sugar stability. However, the study notes that all 1,106 participants were from China, which may limit the generalizability of the results to other cultural dietary patterns. Additionally, the overall certainty of evidence was rated as low to moderate using the GRADE system. Future research should focus on large-scale, multi-center trials across diverse geographic regions to establish global standardized protocols for PDC.

Summary updated

Abstract

https://www.crd.york.ac.uk/prospero/, identifier CRD42023481621.
BibTeX
@inproceedings{lin2024role,
  author = {Dezhi Lin and Hui Wang and Yangxu Ou and Longlong Li and Qiang Zhang and Jiayin Yan and Dezhong Peng and Sihan Peng},
  title = {{The role of diet in diabetes gastroparesis treatment: a systematic review and meta-analysis}},
  booktitle = {Frontiers in Endocrinology},
  year = {2024},
  doi = {10.3389/fendo.2024.1379398},
}
Figure